Atopic dermatitis in children has become an important public health concern. The prevalence of the condition has trebled in the past 20 years, reaching 15%–20% in Western countries , and this continuing upward rise shows no signs of being reversed. Atopic dermatitis affects primarily infants and children, with the age of onset typically between 3 and 6 months old, and this is one of the major challenges in contemporary paediatric dermatology.
KeywordsBurning Corticosteroid Flare Cyclosporin Glaucoma
Unable to display preview. Download preview PDF.
- 1.Aly R (1980) Bacteriology of atopic dermatitis. Acta Derm Venerol (Stockh) Suppl 92: 16–18Google Scholar
- 6.Bridgett C, Noren P, Staughton R (1996) Atopic skin disease. A manual for practitioners. Wrightson Biomedical Publishing, PetersfieldGoogle Scholar
- 10.Hanifin J, Leung D, Palier A, Rico MJ (2003) Tacrolimus ointment monotherapy is safe and effective for the long-term treatment [more than 3 years] of atopic dermatitis in pediatric patients. 59th Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Denver, USA, March 7–12, abstractGoogle Scholar
- 15.Kawashima M, Harada S, Tamaki K (1997) A safety study of FK506 ointment in patients with atopic dermatitis. J Clin Ther Med 13: 1483–1492Google Scholar
- 29.Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C (1982) Cushing’s syndrome after topical application of corticosteroid. Am J Dis Child 136: 247–275Google Scholar
- 30.Stiehm ER, Roberts RL, Kaplan MS, Jonathan Corren J, Rico MJ, Parker JC (2003) Tacrolimus ointment does not alter the immune system of children aged 2–12. 59th Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Denver, USA, March 7–12, abstractGoogle Scholar